NASDAQ Globenewswire

MassRoots Names MyDx the Official Marijuana Analyzer of the Cannabis Community

MassRoots Names MyDx the Official Marijuana Analyzer of the Cannabis Community

Denver, CO (August 27, 2015): MassRoots, Inc. (OTCQB: MSRT), one of the largest and fastest growing social networks for cannabis consumers, is pleased to announce it has named MyDx, Inc.’s (OTCQB: MYDX) MyDx device the official marijuana analyzer of the cannabis community. After crowd-funding nearly $40,000 from 187 supporters on Indiegogo, MyDx launched their hand-held analyzer earlier this summer, giving consumers the ability to test strains of cannabis to determine how they will affect such ailments as stress, anxiety and pain.

“The strong grassroots support the MyDx analyzer has already received proves there is considerable interest from cannabis consumers to learn more about the strains and products they purchase,” stated MassRoots CEO Isaac Dietrich. “The MyDx device will empower regular cannabis enthusiasts to more properly medicate, avoid harmful contaminants and consume in a safer and more responsible manner. We look forward to sharing that message with our 475,000 users and hopefully, improving the quality of their lives.”

“MyDx will help people Trust & VerifyTM what they put into their minds and bodies” said MyDx Founder Daniel Yazbeck. “Our first sensor and application, CannaDx, analyzes and reports the broader Cannabinoid and Terpene content of Cannabis flower samples and asks the consumer: how did this make you feel and what did it help you relieve? The more you test and report your feelings, the more intelligent your personalized recommendation engine in the MyDx App will become, so you can find and track the best the strain profiles that work for you.”

For more information and to purchase the MyDx device, please visit www.mydxlife.com. Follow MyDx on MassRoots under the username, “MyDx.”

About MyDx, Inc. (MyDx Analyzer Video Link)

MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the purity of what they eat, drink and inhale in the palm of their hands and in real time. The Company has developed MyDx, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that will be compatible with the MyDx Analyzer and App. For more information, please visit www.mydxlife.com.

About MassRoots

MassRoots is one of the largest and most active communities of cannabis consumers with 475,000 users. It is proud to be affiliated with the leading organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots has been covered by CNN, Fox Business, CNBC, Fortune, BBC, Cannabist and the New York Times. For more information, please visit Corporate.MassRoots.com.

This information does not constitute an offer to sell or a solicitation of an offer to buy securities or assets of MassRoots. All information presented herein with respect to the existing business and the historical operating results of MassRoots and estimates and projections as to future operations, the success of events that we are attending, and other information, is based on materials prepared by the management of MassRoots and involve significant elements of subjective judgment and analysis which may or may not be correct. While the information provided herein is believed to be accurate and reliable, MassRoots makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. In furnishing this information, MassRoots reserves the right to amend or replace some or all of the information herein at any time and undertakes no obligation to provide the recipient with access to any additional information. Nothing contained herein is or should be relied upon as a promise or representation as to the future.

Forward-looking Statements:

Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ advertising business, potential partnerships, and our related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Important factors that could cause our actual results to differ materially from those anticipated by the statements made herein include, among others, the success of our advertising initiatives, the continued growth and engagement of our user base, our ability to work with partners of the Company, and unforeseen technical or other problems or issues that could affect the performance of our products or our business. Further information on our risk factors is contained in our filings with the SEC, including the Post Effective Amendment to our S-1 Registration Statement filed with the SEC on August 11, 2015. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them.  Any forward-looking statement made by us herein speaks only as of the date on which it is made. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

Contact:

Isaac Dietrich
MassRoots, Inc.
Isaac@MassRoots.com
720.442.0052

Daniel Yazbeck
MyDx, Inc.
Daniel@CDxLife.com
800.814.4550

MyDx Announces Release of Their First Chemical Analyzer for Consumers

The CannaDx Sensor & Smartphone App Empowers Users with the Ability to Test and Rate Cannabis Strains

NASA SUPPORTED SCIENCE & TECHNOLOGY POWERS NEW MYDX CONSUMER CANNABIS ANALYZER

Product Photo Attached

SAN DIEGO, July 14, 2015 (GLOBE NEWSWIRE) — MyDx, Inc. creator of MyDx™ (My Diagnostic), the first battery operated, handheld, chemical analyzer for consumers, has begun the nationwide roll-out of their initial product containing the CannaDx™ sensor and App, designed to help consumers test and find a Cannabis strain that works for them.

The MyDx Analyzer is now being sold online at www.mydxlife.com and via wholesale distribution partners. The MyDx App is available for iOS and Android devices through the Apple App Store and Google Play.

MyDx uses interchangeable sensors to test solids, liquids and gases of interest to reveal their chemical composition. MyDx Started as a crowd funding campaign on Indiegogo and incorporates proprietary “electronic nose” technology formerly used by NASA. Samples “sniffed” by the sensorare sent via Bluetooth to the MyDx App, giving users a chemical profile of  their sample and asking them, “How did this make you feel?” or “What did it help you relieve?”

Following the launch of the CannaDx sensor, additional planned products include OrganaDx™ for pesticides in food, AquaDx™ for chemicals in water, and AeroDx™ for pollutants in the air, which would complete the founders’ mission to offer consumers a quick, easy and affordable way to test the safety and composition of what they eat, drink and inhale.

“Thanks to the feedback from the 220 Beta customers who were the first to pre-order and test our analyzer in the field, we are excited to officially launch our first product.” said Daniel Yazbeck, Chairman and CEO of MyDx. “With our manufacturing capability, strong pre-orders, and distribution pipeline in place, we are now officially shipping units to customers nationwide.”

Cannabis contains over 400 different chemicals that can affect feelings and  relieve ailments such as stress, anxiety and pain.  The CannaDx sensor measures the levels of key chemicals of interest, including Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Terpenes.

“Our vision for this first application is to empower individual consumers to test the broader chemical profile of their cannabis samples and correlate it to how it makes them feel so they can more consistently find a strain that works for them,” continued Yazbeck, a former scientist for Pfizer Pharmaceuticals and new product & market developer for Panasonic. “We believe our technology is disruptive, and consumers will benefit from greater accessibility to testing.”

About the MxDx Analyzer

The company’s first product suite includes the MyDx AnalyzerCannaDx SensorDisposable Sample Inserts, and the free MyDx App. Together, the solution analyzes and tracks the chemical profiles present and feelings associated with a given cannabis sample. Pricing for the unit, which can accommodate multiple sensors for different applications, is $699.00.

Unit Features: 

  • Real-time measurement of the chemical profile of the plant, including cannabinoids and terpenes
  • Handheld, battery operated and fits in your back pocket
  • Easy to use (no training required other than operating a smartphone)
  • Tracking journal of what you tested and how it made you feel
  • Recommendation engine that leverages your data to recommend strains that will work for you

More information is available on the company’s website at www.mydxlife.com and accompanying overview video at www.mydxlife.com/overview-video.

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to help people Trust & VerifyTM what they put into their minds and bodies. The Company has developed MyDx, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx Analyzer and App. For more information, please visit www.mydxlife.com.

Safe Harbor

This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.

A photo accompanying this release is available at:

http://www.globenewswire.com/newsroom/prs/?pkgid=34449

See more at: http://globenewswire.com/news-release/2015/07/14/751811/10141592/en/MyDx-Announces-Release-of-Their-First-Chemical-Analyzer-for-Consumers.html#sthash.nKeVCIFA.dpuf

CDx CEO Featured Panelist at Marijuana Investor, Technology and Healthcare Events

MyDx, Inc. was featured at several events including the Marijuana Investor Summit and Med MJ conferences in Denver, Colorado, where we participated in panels covering Technology and Software in the MMJ Space. We are also grateful for the opportunity to contribute to the “Shark Tank” Panel sessions at the Arcview Investor Forum in Washington, DC., the same forum where CDx kicked off its Series A financing activities back in January of 2014.